CAS 714971-87-6

9H-Xanthene-9-carboxamide, N-[4-(trifluoromethyl)-2-oxazolyl]-

Description:

9H-Xanthene-9-carboxamide, N-[4-(trifluoromethyl)-2-oxazolyl]- is a chemical compound characterized by its xanthene core structure, which is a polycyclic aromatic compound featuring a fused benzene and a dibenzofuran ring system. The presence of a carboxamide functional group indicates that it can participate in hydrogen bonding, influencing its solubility and reactivity. The substitution of a trifluoromethyl group on the oxazole ring enhances the compound's lipophilicity and may affect its biological activity, making it of interest in medicinal chemistry. The oxazole moiety contributes to the compound's overall stability and can also influence its electronic properties. This compound may exhibit fluorescence due to the xanthene structure, which is often utilized in dye applications. Its unique combination of functional groups suggests potential applications in pharmaceuticals, particularly in the development of compounds with specific biological activities. As with many synthetic organic compounds, its properties, such as solubility, melting point, and reactivity, would need to be characterized through experimental methods for precise applications.

Formula: C₁₈H₁₁F₃N₂O₃

Synonyms:

• 9H-Xanthene-9-carboxamide, N-[4-(trifluoromethyl)-2-oxazolyl]-
• Ro0711401

N-(4-(Trifluoromethyl)oxazol-2-yl)-9H-xanthene-9-carboxamide

CAS: 714971-87-6

Formula: C₁₈H₁₁F₃N₂O₃

Purity: 99%

Color and Shape: Solid

Molecular weight: 360.2867

Ref: IN-DA01V4HY

Ro0711401

CAS: 714971-87-6

Ro0711401

Purity: ≥95%

Molecular weight: 360.29g/mol

Ref: 54-BUP13028

Ro0711401

CAS: 714971-87-6

Ro0711401 is an agonist of mGlu1 receptor.

Formula: C₁₈H₁₁F₃N₂O₃

Purity: 97.57%

Color and Shape: Solid

Molecular weight: 360.29

Ref: TM-T9021

N-(4-(Trifluoromethyl)oxazol-2-yl)-9H-xanthene-9-carboxamide

CAS: 714971-87-6

N-(4-(Trifluoromethyl)oxazol-2-yl)-9H-xanthene-9-carboxamide is a novel, low expression, partial agonist for the α receptor. It has been shown to have an inhibitory effect on glutamate release and has been successfully used to reverse drug induced excitotoxicity in mice. N-(4-(Trifluoromethyl)oxazol-2-yl)-9H-xanthene-9-carboxamide also enhances allosteric modulation at the α receptor with a high affinity for this site. This compound has also been shown to have a pharmacological effect on brain cells and may be useful as a treatment for neurodegenerative disorders.

Formula: C₁₈H₁₁F₃N₂O₃

Purity: Min. 95%

Molecular weight: 360.3 g/mol

Ref: 3D-PDB97187